March 10, 2017
Synairgen: inhibition of LOXL2 has the potential to improve lung function
Synairgen has reported more positive data from its LOXL2 (lysyl oxidase-like 2 enzyme) inhibitor programme against the lung disease idiopathic pulmonary…